About
Dyslipidemia treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Team (8)
Board Committees
Independent Directors
Matinas Biopharma
team_member
Edward Neugeboren
Matinas Biopharma
team_member
Evelyn D’An
Matinas Biopharma
team_member
Executive Team
Co-founder, Chairman & Chief Executive Officer
Matinas Biopharma
board_chairexecutivefounder
Infectious Disease Experts - MAT2203
Professor of Internal Medicine and Attending Physician, Uniklinik Köln
Matinas Biopharma
team_member
Jerome D. Jabbour
Matinas Biopharma
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
2
As Collaborator
2
Total Enrollment
1,148
By Phase
PHASE3: 1PHASE2: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 2WITHDRAWN: 1RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT04662528Lead Sponsor
Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL
PHASE3Withdrawn
Started: Jun 30, 2021 · Completed: Oct 31, 2022
NCT04177680Collaborator
Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia
PHASE2Completed
100 participants
Started: Jun 3, 2020 · Completed: Jan 18, 2021
NCT02310022Lead Sponsor
A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
PHASE1/PHASE2Completed
48 participants
Started: Nov 30, 2014 · Completed: Aug 31, 2016
NCT01731353Collaborator
FungiScope - A Global Emerging Fungal Infection Registry
N/ARecruiting
1,000 participants
Started: Mar 31, 2003 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Bedminster, NJ, United States
Map
Loading map...